Brief: Bone Therapeutics Changes Name To Biosenic, Following The Acquisition Of A Majority Participation Of Medsenic Valued At EUR 40 Million

Biosenic SA

25/10/2022 07:21

Oct 25 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * BONE THERAPEUTICS TO START A NEW EURONEXT EQUITY STORY
WITH A
CHANGE OF NAME TO BIOSENIC, FOLLOWING THE ACQUISITION OF A
MAJORITY PARTICIPATION OF MEDSENIC VALUED AT EUR 40 MILLION

Source text for Eikon:  ID:nGNE14FFSy 
Further company coverage:  BOTHE.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))